COVID-19: molecular targets, drug repurposing and new avenues for drug discovery
Mem. Inst. Oswaldo Cruz
; 115: e200254, 2020. tab, graf
Article
in En
| LILACS, SES-SP
| ID: biblio-1135246
Responsible library:
BR1.1
ABSTRACT
Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious infection that may break the healthcare system of several countries. Here, we aimed at presenting a critical view of ongoing drug repurposing efforts for COVID-19 as well as discussing opportunities for development of new treatments based on current knowledge of the mechanism of infection and potential targets within. Finally, we also discuss patent protection issues, cost effectiveness and scalability of synthetic routes for some of the most studied repurposing candidates since these are key aspects to meet global demand for COVID-19 treatment.
Key words
Full text:
1
Index:
LILACS
Main subject:
Pneumonia, Viral
/
Coronavirus Infections
/
Drug Discovery
/
Drug Repositioning
Limits:
Humans
Language:
En
Journal:
Mem. Inst. Oswaldo Cruz
Journal subject:
MEDICINA TROPICAL
/
PARASITOLOGIA
Year:
2020
Type:
Article